Febrile Seizures: Interleukin 1β and Interleukin-1 Receptor Antagonist Polymorphisms

被引:32
|
作者
Serdaroglu, Gul [1 ]
Alpman, Asude [2 ]
Tosun, Ayse [1 ]
Pehlivan, Sacide [2 ]
Oezkmay, Ferda [2 ]
Tekguel, Hasan [1 ]
Goekben, Sarenur [1 ]
机构
[1] Ege Univ, Sch Med, Div Child Neurol, Dept Pediat, TR-35100 Izmir, Turkey
[2] Ege Univ, Sch Med, Dept Genet, TR-35100 Izmir, Turkey
关键词
NECROSIS-FACTOR-ALPHA; TAIWANESE CHILDREN; SUSCEPTIBILITY; CONVULSIONS; CYTOKINES; PROMOTER; EPILEPSY; ALLELE;
D O I
10.1016/j.pediatrneurol.2008.10.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In order to investigate the association between IL-1 beta-511 C -> T and IL-1 receptor antagonist intron 2 variable tandem repeat polymorphisms, and febrile seizures in children, 90 children (mean age, 19.7 +/- 11.2 months) diagnosed with febrile seizure and 106 healthy controls (mean age, 14.2 +/- 3.6 months) with no seizure or neurologic events were included in the study. The polymorphisms were analyzed using restriction fragment length polymorphism and agarose gel electrophoresis methods. In the patient group, the frequencies of IL-1 beta genotypes CC, CT, and TT were 24.4%, 52.2%, and 23.3%, respectively, compared with 38.7%, 50.95%, and 10.4%, respectively, in the control group. The TT genotype was significantly more common in the patient group than in the control group (P = 0.044), and the T allele frequency was significantly higher in the patient group (0.50 vs 0.36, P = 0.040). Among the three genotypes (RN1/1, RN1/2, and RN2/2) of the IL receptor antagonist gene variable tandem repeat polymorphisms, the frequency of both the RN2/2 genotype and the RN2 allele were significantly higher in the patient group (P = 0.007). Also RN2 allele frequency was found higher in patient group than controls (0.29 vs 0.15, P = 0.020). IL-1 beta-511 and IL-1 receptor antagonist intron 2 variable tandem repeat polymorphisms may be involved in susceptibility to febrile convulsions in children. (C) 2009 by Elsevier Inc. All rights reserved.
引用
收藏
页码:113 / 116
页数:4
相关论文
共 50 条
  • [41] Analysis of Polymorphisms in Interleukin-10, Interleukin-6, and Interleukin-1 Receptor Antagonist in Mexican-Mestizo Women with Pre-eclampsia
    Valencia Villalvazo, Elith Yazmin
    Canto-Cetina, Thelma
    Romero Arauz, Juan Fernando
    Mauricio Coral-Vazquez, Ramon
    Canizales-Quinteros, Samuel
    Coronel, Agustin
    Carlos Falcon, Juan
    Hernandez Rivera, Jaime
    Ibarra, Roberto
    Polanco Reyes, Lucila
    Canto, Patricia
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2012, 16 (11) : 1263 - 1269
  • [42] Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms in Greek multiple sclerosis (MS) patients with bout-onset MS
    Aggelakis, Konstantinos
    Zacharaki, Fani
    Dardiotis, Efthimios
    Xiromerisiou, Georgia
    Tsimourtou, Vana
    Ralli, Styliani
    Gkaraveli, Maria
    Bourpoulas, Dimitris
    Rodopoulou, Paraskevi
    Papadimitriou, Alexandros
    Hadjigeorgiou, Georgios
    NEUROLOGICAL SCIENCES, 2010, 31 (03) : 253 - 257
  • [43] Comparison of two polymorphisms of the interleukin-1 gene family:: Inteuleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis
    Fang, XM
    Schröder, S
    Hoeft, A
    Stüber, F
    CRITICAL CARE MEDICINE, 1999, 27 (07) : 1330 - 1334
  • [44] CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma
    Stocker, Gertraud
    Ott, Katja
    Henningsen, Nils
    Becker, Karen
    Hapfelmeier, Alexander
    Lordick, Florian
    Hois, Stefan
    Plaschke, Susanne
    Hoefler, Heinz
    Keller, Gisela
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (18) : 3326 - 3335
  • [45] The interleukin-1 family gene polymorphisms and Graves' disease
    Khalilzadeh, O.
    Anvari, M.
    Esteghamati, A.
    Momen-Heravi, F.
    Mahmoudi, M.
    Rashidi, A.
    Amiri, H. M.
    Ranjbar, M.
    Tabataba-Vakili, S.
    Amirzargar, A.
    ANNALES D ENDOCRINOLOGIE, 2010, 71 (04) : 281 - 285
  • [46] Interleukin-1 receptor antagonist allele 2 and familial alopecia areata
    Barahamani, N
    de Andrade, M
    Slusser, J
    Zhang, Q
    Duvic, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 118 (02) : 335 - 337
  • [47] Inhibition of Adjuvant Arthritis in Rats by Electroporation with Interleukin-1 Receptor Antagonist
    Sukedai, Miho
    Ariyoshi, Wataru
    Okinaga, Toshinori
    Iwanaga, Kenjiro
    Habu, Manabu
    Yoshioka, Izumi
    Tominaga, Kazuhiro
    Nishihara, Tatsuji
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2011, 31 (11) : 839 - 846
  • [49] Large-scale meta-analysis of interleukin-1 beta and interleukin-1 receptor antagonist polymorphisms on risk of radiographic hip and knee osteoarthritis and severity of knee osteoarthritis
    Kerkhof, H. J. M.
    Doherty, M.
    Arden, N. K.
    Abramson, S. B.
    Attur, M.
    Bos, S. D.
    Cooper, C.
    Dennison, E. M.
    Doherty, S. A.
    Evangelou, E.
    Hart, D. J.
    Hofman, A.
    Javaid, K.
    Kerna, I.
    Kisand, K.
    Kloppenburg, M.
    Krasnokutsky, S.
    Maciewicz, R. A.
    Meulenbelt, I.
    Muir, K. R.
    Rivadeneira, F.
    Samuels, J.
    Sezgin, M.
    Slagboom, E.
    Smith, A. J. P.
    Spector, T. D.
    Tamm, A.
    Tamm, A.
    Uitterlinden, A. G.
    Wheeler, M.
    Zhai, G.
    Zhang, W.
    van Meurs, J. B. J.
    Valdes, A. M.
    OSTEOARTHRITIS AND CARTILAGE, 2011, 19 (03) : 265 - 271
  • [50] REGULATION OF MONOCYTE-DERIVED INTERLEUKIN-1 RECEPTOR ANTAGONIST BY CISPLATINUM
    ARENBERG, DA
    KUNKEL, SL
    BURDICK, MD
    STANDIFORD, TJ
    STRIETER, RM
    CYTOKINE, 1995, 7 (01) : 89 - 96